Roche

The first fully automated diagnostic solution to identify the most severe form of viral hepatitis is finally here, helping clinicians address the urgent need for a consistent, widely accessible solution. roche.com/media $RHHBY $ROG Available in countries accepting the CE mark. For in vitro diagnostic use. Please consult the Instructions for Use for complete product information, including intended use and limitations.

@esmaaberberr Also please contact us Directly on our DM for further information. Ana at team Roche

Olcumler arasında90birime kadar fark var.Libreden markaniza gecmistim.Hic memnun kalmadım.Sağlığımı riske attım.Param boşa gitti.Parmak ölçümünde%100başarılı bir markanın cgmde bu kadar başarısız olması maddi manevi üzdü.Başka markaya geçeceğim @Roche

We’re so sorry to hear this, Esma. So we can help you resolve this issue, please submit your complaint here: accu-chek.com/contact. In the meantime, you can also get guidance from our Diabetes Care Team. Just follow the link to find your local office: roche.com/about/business… Wishing you all the very best, Ana at Team Roche

We're at #AAIC26! Come by booth to speak to our team about the latest advancements in Alzheimer’s. We look forward to meeting you! 👋

Just 19 minutes per patient to process. Under 24 hours to results. ⏱️ A new blood test for tuberculosis infection is giving labs the efficiency they need to handle growing global testing demands. Faster testing means we're one step closer to global TB elimination. 🌍 roche.com/media $RHHBY $ROG

#MEDIA – We are pleased to share that Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at #AAIC26. Learn more 👉 roche.com/media

#MEDIA We are pleased to share that our Phase III study in advanced #KRAS G12C-positive #NSCLC met its primary endpoint, demonstrating positive top-line results. Read more here: roche.com/media/releases

The Bundibugyo virus is a rare and deadly strain of #Ebola that often escapes detection by commonly used frontline tests. That’s why containing outbreaks while providing critical surveillance to monitor any further spread is vital. Our commitment to reinforcing healthcare infrastructure remains absolute, ensuring communities are better equipped to minimize the burden of infectious diseases. #Innovation #PandemicPreparedness

#MEDIA - We are pleased that the US FDA has accepted the supplemental Biologics License Application (sBLA) for our investigational medicine for thyroid eye disease (TED). 👉 roche.com/media

@sciqst Thank you for sharing your perspective! We are excited to see how this ultra-fast, real-time data flow will help the global research community streamline their pipelines and accelerate discoveries in complex disease research. 🧬 #RocheSBX Ana at team Roche

Impressive advancements by Roche! The capability to achieve same-day whole genome sequencing can significantly accelerate research timelines. It would be fascinating to see how this innovation impacts areas like personalized medicine and disease research. How do you perceive its integration into current research workflows? For more in-depth exploration of such biomedical advancements, check out Sci-Quest—your one-stop platform for generating comprehensive biomedical reviews: sciqst.com. #Medicine #Genomics #ResearchInnovation

#MEDIA - Roche’s sequencing platform is now available for research use, capable of same‑day whole genome sequencing in research workflows, demonstrating end‑to‑end whole‑genome results within hours. roche.com/media/releases #Genomics #HumanGenetics #RocheSBX #Innovation #NGS $ROG $RHHBY

#MEDIA – We are pleased to announce that the US FDA has accepted Roche’s supplemental Biologics License Application for a new bispecific antibody combination treatment for people with relapsed or refractory large B-cell lymphoma (#LBCL). #Lymphoma #BCELL 🔗 spkl.io/60117E8Xb

As the @EHA_Hematology Congress (#EHA2026) kicks off, hear from Steve Tuplin, Haematology Franchise Head at Roche, on our commitment to exploring combination approaches that advance B-cell malignancy outcomes. 👇

Dear Dr. Prasad We are very sorry to hear about this. To help you resolve the issue, please contact our local team at 1800 120 6020 or via email at india.accu-chek@roche.com You can also visit Accu-Chek India Contact Us - accu-chek.in/contact-us In the meantime, we have forwarded your concern to the relevant team as well. We hope this issue is resolved soon, Ana at Team Roche

@accuchekindia @roche till complaint not solved. Poor service good bye to accucheck india

#MEDIA – We are pleased that the US FDA has accepted the New Drug Application for our investigational medicine in ER-positive early-stage #BreastCancer in the adjuvant setting spkl.io/6010764LG $ROG $RHHBY

Hi Marah Thank you for getting in touch with us.To ensure that the right team takes care of your request, we would invite you to get in touch with our office in your country. You can find a list of all Roche offices at this link: roche.com/about/business… Or contact us at lifescience.roche.com/global/en/cont… Wishing you all the very best. Ana at Team Roche

Mass spectrometry is transforming diagnostics, but simply having the tech isn't enough. The real breakthrough comes from seamlessly integrating it into the lab's entire workflow. Hear from Roche’s Benjamin Lilienfield about the value of integration to healthcare labs. go.roche.com/bjms #RocheMassSpec

#MEDIA - Chronic liver disease causes more than two million deaths worldwide every year, despite 90% of cases being preventable. To help address this, Roche is launching a comprehensive Liver Disease Panel, featuring certified algorithms to improve early detection. roche.com/media/releases #DigitalHealth #EarlyDetection #CLD

@gardp_amr Thank you! It was an honour to co-host this vital discussion on global health security at #WHA79 Kat at Team Roche

At #WHA79, GARDP joined critical conversations, shaping the global response to antimicrobial resistance. From a @reactgroup roundtable calling for funded National Action Plans, accountable systems and LMIC representation at the heart of decision-making, to a @Roche & @MedsPatentPool discussion on anticipatory investment and long-term public-private collaboration — the week underscored that innovation, access and stewardship must be treated as global public goods. Thank you to @EC_HERA , @pahowho, ReAct, Roche, MPP and all partners championing collective action against #AMR. #AMR #WorldHealthAssembly #AntibioticResistance #GlobalHealth

Big News from the World Health Assembly! 🌍 Roche and the @MedsPatentPool sign voluntary license agreement to expand global access to innovative antiviral medicine in low-and-middle income countries and strengthen global health resilience against influenza 🏥 For more information, visit: spkl.io/6018Ah9SC #GlobalHealth #AccesstoMedicines #HealthSecurity #GlobalHealthSecurity #PandemicPreparedness #VoluntaryLicensing #WHA79